Cargando…
Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer
BACKGROUND: Several studies have documented that blood biomarkers can improve basic prognostic models in radiotherapy and radio-chemotherapy for non-small cell lung cancer. The current study evaluated the prognostic impact of six markers focusing on their utility in homogenous subsets, compared to t...
Autores principales: | Suwinski, Rafał, Giglok, Monika, Galwas-Kliber, Katarzyna, Idasiak, Adam, Jochymek, Bozena, Deja, Regina, Maslyk, Barbara, Mrochem-Kwarciak, Jolanta, Butkiewicz, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507220/ https://www.ncbi.nlm.nih.gov/pubmed/31068179 http://dx.doi.org/10.1186/s12885-019-5617-1 |
Ejemplares similares
-
Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy
por: Butkiewicz, Dorota, et al.
Publicado: (2021) -
A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy
por: Maślak, Ewelina, et al.
Publicado: (2022) -
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
por: Zajkowicz, A, et al.
Publicado: (2015) -
Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer
por: Mazurek, Agnieszka M., et al.
Publicado: (2023) -
Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis
por: Chen, Ming-Yuan, et al.
Publicado: (2013)